Pyxis Oncology Financials - Benzinga

Pyxis Oncology Inc

PYXSNASDAQ

Trade with Public

Trade with Public

$3.23

-0.09-2.71%

At close: Aug 28, 5:00 PM EST

$3.23

-0.0003-0.01%

After Hours: 4:38 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Pyxis Oncology Financials

Pyxis Oncology (PYXS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Pyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 33.33 percent decrease over losses of $(0.30) per share from

Benzinga Newsdesk

PRO
Pyxis Oncology Q1 EPS $(0.37), Inline

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.37) per share which met the analyst consensus estimate. This is a 5.71 percent decrease over losses of $(0.35) per share from the same period last year.

Benzinga Newsdesk

PRO
Pyxis Oncology Q4 EPS $(0.29) Beats $(0.33) Estimate, Sales $11.038M

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.33) by 12.65 percent. This is a 50.85 percent increase over losses of $(0.59) per share from

Benzinga Newsdesk

Nasdaq Gains Over 200 Points; US Inflation Slows To 2.7%

Avi Kapoor

PRO
Pyxis Oncology Q3 EPS $(0.35) Misses $(0.34) Estimate

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 2.04 percent. This is unchanged from the same period last year.

Benzinga Newsdesk

PRO
Pyxis Oncology Q2 EPS $(0.30) Beats $(0.35) Estimate, Sales $2.82M

Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.35) by 14.77 percent. This is a 3.45 percent decrease over losses of $(0.29) per share from the

Benzinga Newsdesk